Abellio London Bus, one of London’s most innovative public transport companies, has become the first bus operator to adopt fingerprint-based drug testing technology to support the health and safety of its employees and customers. Abellio operates day and night bus services across London, and will use the portable Intelligent Fingerprinting drug screening system to support random, for cause and post-incident drug testing for its 2,100 drivers and 200 other safety-critical employees. Alcohol testing will also take place at the same time. Adopting the Intelligent Fingerprinting solution will enhance Abellio’s previous urine-based testing approach, which proved challenging in terms of observed sample collection, the requirement for gender-specific testing staff and specially-prepar

Join for free to read